| pubmed-article:3311770 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:3311770 | lifeskim:mentions | umls-concept:C0235032 | lld:lifeskim |
| pubmed-article:3311770 | lifeskim:mentions | umls-concept:C0085845 | lld:lifeskim |
| pubmed-article:3311770 | lifeskim:mentions | umls-concept:C0813872 | lld:lifeskim |
| pubmed-article:3311770 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:3311770 | pubmed:dateCreated | 1987-12-16 | lld:pubmed |
| pubmed-article:3311770 | pubmed:abstractText | Using the ex vivo chick embryo retina to study the efficacy of antagonists in blocking the excitotoxic effects of excitatory amino acid agonists, we previously identified phencyclidine as the most powerful known anti-excitotoxin. Here we show that MK-801 is 5 times more powerful than phencyclidine as an anti-excitotoxin, that its antagonism is specific for N-methyl-asparate toxicity, is non-competitive and does not entail inhibition of excitatory amino acid receptor binding. | lld:pubmed |
| pubmed-article:3311770 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3311770 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3311770 | pubmed:language | eng | lld:pubmed |
| pubmed-article:3311770 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3311770 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:3311770 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3311770 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3311770 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3311770 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3311770 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3311770 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3311770 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3311770 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:3311770 | pubmed:month | Sep | lld:pubmed |
| pubmed-article:3311770 | pubmed:issn | 0014-2999 | lld:pubmed |
| pubmed-article:3311770 | pubmed:author | pubmed-author:OlneyJJ | lld:pubmed |
| pubmed-article:3311770 | pubmed:author | pubmed-author:PriceMM | lld:pubmed |
| pubmed-article:3311770 | pubmed:author | pubmed-author:SallesK SKS | lld:pubmed |
| pubmed-article:3311770 | pubmed:author | pubmed-author:LabruyereJJ | lld:pubmed |
| pubmed-article:3311770 | pubmed:author | pubmed-author:FrierdichGG | lld:pubmed |
| pubmed-article:3311770 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:3311770 | pubmed:day | 23 | lld:pubmed |
| pubmed-article:3311770 | pubmed:volume | 141 | lld:pubmed |
| pubmed-article:3311770 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:3311770 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:3311770 | pubmed:pagination | 357-61 | lld:pubmed |
| pubmed-article:3311770 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
| pubmed-article:3311770 | pubmed:meshHeading | pubmed-meshheading:3311770-... | lld:pubmed |
| pubmed-article:3311770 | pubmed:meshHeading | pubmed-meshheading:3311770-... | lld:pubmed |
| pubmed-article:3311770 | pubmed:meshHeading | pubmed-meshheading:3311770-... | lld:pubmed |
| pubmed-article:3311770 | pubmed:meshHeading | pubmed-meshheading:3311770-... | lld:pubmed |
| pubmed-article:3311770 | pubmed:meshHeading | pubmed-meshheading:3311770-... | lld:pubmed |
| pubmed-article:3311770 | pubmed:meshHeading | pubmed-meshheading:3311770-... | lld:pubmed |
| pubmed-article:3311770 | pubmed:meshHeading | pubmed-meshheading:3311770-... | lld:pubmed |
| pubmed-article:3311770 | pubmed:meshHeading | pubmed-meshheading:3311770-... | lld:pubmed |
| pubmed-article:3311770 | pubmed:meshHeading | pubmed-meshheading:3311770-... | lld:pubmed |
| pubmed-article:3311770 | pubmed:meshHeading | pubmed-meshheading:3311770-... | lld:pubmed |
| pubmed-article:3311770 | pubmed:meshHeading | pubmed-meshheading:3311770-... | lld:pubmed |
| pubmed-article:3311770 | pubmed:meshHeading | pubmed-meshheading:3311770-... | lld:pubmed |
| pubmed-article:3311770 | pubmed:meshHeading | pubmed-meshheading:3311770-... | lld:pubmed |
| pubmed-article:3311770 | pubmed:meshHeading | pubmed-meshheading:3311770-... | lld:pubmed |
| pubmed-article:3311770 | pubmed:year | 1987 | lld:pubmed |
| pubmed-article:3311770 | pubmed:articleTitle | MK-801 powerfully protects against N-methyl aspartate neurotoxicity. | lld:pubmed |
| pubmed-article:3311770 | pubmed:affiliation | Department of Psychiatry, Washington University School of Medicine, St. Louis, MO 63110. | lld:pubmed |
| pubmed-article:3311770 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:3311770 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:3311770 | pubmed:publicationType | Research Support, U.S. Gov't, Non-P.H.S. | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3311770 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3311770 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3311770 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3311770 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3311770 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3311770 | lld:pubmed |
